Nov 16, 2012
Epstein-Barr virus (EBV) is the cause of infectious mononucleosis and a risk for serious disease in liver transplant recipients. Molecular tests that can identify early protein markers produced by EBV may have value for diagnosing active infection.
Nov 13, 2012
Radiolabeled agents are powerful tools for targeting and killing cancer cells and may help improve outcomes and lengthen survival times of patients with advanced disease that has spread beyond the initial tumor site.
Nov 08, 2012
Concussion is a common disorder estimated to affect no fewer than 1.7-3.8 million people in the U.S. each year.
Oct 22, 2012
New, advanced techniques are needed that can mimic the normal blood supply that feeds natural bone to improve the viability and success of restorative procedures to replace damaged or diseased bone tissue using engineered constructs.
Oct 12, 2012
Human Gene Therapy is expanding its editorial coverage with the launch of Human Gene Therapy Clinical Development early next year.
Oct 12, 2012
Mary Ann Liebert, Inc., publishers and the editorial leadership of the peer-reviewed journal Stem Cells and Development congratulate Sir John Gurdon and Shinya Yamanaka on being awarded the Nobel Prize for Physiology or Medicine.
Sep 19, 2012
Many biotech observers maintain that the future of healthcare will largely be based on the field of personalized medicine, reports Genetic Engineering & Biotechnology News (GEN).
Sep 10, 2012
Therapies for retinal diseases are expected to overtake those for glaucoma by 2014, reports Genetic Engineering & Biotechnology News (GEN).
Sep 05, 2012
According to the Centers for Disease Control and Prevention (CDC), 1 in 88 children in the U.S. has autism spectrum disorder (ASD), a broad group of neurodevelopmental disorders.
Sep 04, 2012
The use of RNA in nanotechnology applications is highly promising for many applications, including the development of new therapeutic compounds.